Virus-specific MHC class II-restricted TCR-transgenic mice: Effects on humoral and cellular immune responses after viral infection

European Journal of Immunology

Volumn 28, Issue 1, 1998, Pages 390-400

  Oxenius, Annette ^a,c   Bachmann, Martin F ^a,b   Zinkernagel, Rolf M ^a   Hengartner, Hans ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b BASEL INSTITUTE FOR IMMUNOLOGY   (Switzerland)

^c INSTITUTE OF EXPERIMENTAL IMMUNOLOGY   (Switzerland)

Author keywords

CD4+ T cell; TCR transgenic mouse; Viral infection

Indexed keywords

CD4 ANTIGEN; EPITOPE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; NUCLEOPROTEIN; T LYMPHOCYTE RECEPTOR; VIRUS GLYCOPROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; B LYMPHOCYTE; CELLULAR IMMUNITY; CONTROLLED STUDY; HELPER CELL; HUMORAL IMMUNITY; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MAJOR HISTOCOMPATIBILITY COMPLEX RESTRICTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; TRANSGENIC MOUSE; VIRUS INFECTION;

ADOPTIVE TRANSFER; ANIMALS; ANTIBODIES, VIRAL; CARRIER STATE; CD4-POSITIVE T-LYMPHOCYTES; CLONAL DELETION; CYTOPATHOGENIC EFFECT, VIRAL; EPITOPES; HISTOCOMPATIBILITY ANTIGENS CLASS II; IMMUNITY, CELLULAR; IMMUNOGLOBULIN CLASS SWITCHING; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LYMPHOCYTE COUNT; LYMPHOCYTIC CHORIOMENINGITIS; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; SPECIFIC PATHOGEN-FREE ORGANISMS; T-LYMPHOCYTE SUBSETS; VACCINIA VIRUS; VIRAL PROTEINS; VIRUS REPLICATION;

EID: 0031975635     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1521-4141(199801)28:01<390::AID-IMMU390>3.0.CO;2-O     Document Type: Article

References (47)

1. Hotchin, J., The biology of lymphocytic choriomeningitis infection: Virus induced immune disease. Cold Spring Harbor Symp Quant Biol 1962. 27: 479-499.
2. Kägi, D., Ledermann, B., Bürki, K., Seiler, P., Odermatt, B., Olsen, K. J., Podack, E., Zinkernagel, R. M. and Hengartner, H., Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice. Nature 1994. 369: 31-37.
3. Moskophidis, D., Lechner, F., Pircher, H. P. and Zinkernagel, R. M., Virus persistence in acutely infected immunocompetent mice by exhaustion of antiviral cytotoxic effector T cells. Nature 1993. 362: 758-761.
4. Pircher, H. P., Hoffmann, R. U., Moskophidis, D., Zinkernagel, R. M. and Hengartner, H., Lower receptor avidity required for thymic clonal deletion than for effector T cell function. Nature 1991. 351: 482-485.
5. + T cells. Eur. J. Immunol. 1993. 23: 3306-3311.
6. + T cell deficient mice. J. Virol. 1994. 68: 4700-4704.
7. Muller, D., Koller, B. H., Whitton, J. L., LaPan, K. E., Brigman, K. K. and Frelinger, J. A., LCMV-specific, class II-restricted cytotoxic T cells in beta 2-microglobulin-deficient mice. Science 1992. 255: 1576-1578.
8. Zajak, A. J., Quinn, D. G., Cohen, P. L. and Frelinger, J. A., Fas-dependent CD4+ cytotoxic T-cell-mediated pathogenesis during virus infection. Proc. Natl. Acad. Sci. USA 1996. 93: 14730-14735.
9. La Posta, V. J., Auperin, D. D., Kamin-Lewis, R. and Cole, G. A., Cross-protection against lymphocytic choriomeningitis virus mediated by a CD4+ T cell clone specific for an envelope glycoprotein epitope of Lassa virus. J. Virol. 1993. 67: 3497-3506.
10. Thomsen, A. R., Johansen, J., Marker, O. and Christensen, J. P., Exhaustion of CTL memory and recrudescence of viremia in lymphocytic choriomeningitis virus-infected MHC class II-deficient and B cell deficient mice. J. Immnol. 1996. 157: 3074-3080.
11. + T cells and interferons in persistent and acute infections of mice with lymphocytic choriomeningitis virus: Implications for adoptive immunotherapy of virus carriers. Proc. Natl. Acad. Sci. USA 1997. 94: 6974-4879.
12. + cytotoxic T cell responses during chronic viral infection. J. Virol. 1994. 68: 8056-8063.
13. Leist, T. P., Cobbold, S. P., Waldmann, H., Aguet, M. and Zinkernagel, R. M., Functional analysis of T lymphocyte subsets in antiviral host defense. J. Immunol. 1987. 138: 2278-2281.
14. + T helper cell function in vivo: differential requirement for induction of antiviral cytotoxic T-cell and antibody responses. J. Virol. 1988.62: 2102-2106.
15. Moskophidis, D. and Lehmann-Grube, F., The immune response of the mouse to lymphocytic choriomeningitis virus. VI. Enumeration of antibody-producing cells in spleens during acute and persistent infection. J. Immunol. 1984. 133: 3366-3370.
16. + T cell functions. J. Exp. Med. 1996. 183: 2209-2218.
17. Katz, J. D., Wang, B., Haskins, K., Benoist, C. and Mathis, D., Following a diabetogenic T cell from genesis through pathogenesis. Cell 1993. 74: 1089-1100.
18. Berg, L. J., Pullen, A. M., Fazekas de St. Groth, B., Mathis, D., Benoist, C. and Davis, M. M., Antigen/ MHC-specific T cells are preferentially exported from the thymus in the presence of their MHC ligand. Cell 1989. 58: 1035-1046.
19. + T cells in transgenic mice expressing a class II MHC-restricted antigen receptor. Nature 1989. 341: 746-749.
20. Goverman, J., Woods, A., Larson, L., Weiner, L. P., Hood, L. and Zaller, D. M., Transgenic mice that express a myelin basic protein-specific T cell receptor develop spontaneous autoimmunity. Cell 1993. 72: 551-560.
21. + T cells specific for a pancreatic β cell neo-antigen. Immunity 1995. 2: 563-585.
22. Kettman, J. and Dutton, R. W., An in vitro immune response to 2,4,6-trinitrophenyl-substituted erythrocyte: response against carrier and hapten. J. Immunol, 1970. 104: 1558-1561.
23. Bachmann, M. F., Kündig, T. M., Kalberer, C. P., Hengartner, H. and Zinkernagel, R. M., How many specific B cells are needed to protect against a virus? J. Immunol. 1994. 152: 4235-4241.
24. Turtinen, L. W., Lathey, J. L. and Rouse, B. T., Estimation of precursor frequencies to herpes simplex virus type I glycoproteins by a limiting dilution assay. J. Med. Virol. 1986. 20: 357-362.
25. Charan, S., Hengartner, H. and Zinkernagel, R. M., Primary antibody responses to a well-defined and unique hapten are not enhanced by preimmunization with carrier: Analysis in a viral model. Proc. Natl. Acad. Sci. USA 1986. 83: 2604-2608.
26. Freer, G., Burkhart, C., Rülicke, T., Ghelardi, E., Hoffmann Rohrer, U., Pircher, H., Zinkernagel, R. M. and Hengartner, H., Role of T helper cell precursor frequency on vesicular stomatitis virus neutralizing antibody responses in a T cell receptor β chain transgenic mouse. Eur. J. Immunol. 1995. 25: 1410-1416.
27. Pitcher, H. P., Bürki, K., Lang, R., Hengartner, H. and Zinkernagel, R. M., Tolerance induction in double specific T-cell receptor transgenic mice varies with antigen. Nature 1989. 342: 559-561.
28. Buchmeier, M. J., Welsh, R. M., Dutko, F. J. and Oldstone, M. B. A., The virology and immunobiology of lymphocytic choriomeningitis virus infection. Adv. Immunol. 1980. 30: 275-331.
29. Moskophidis, D., Frei, K., Löhler, J., Fontana, A. and Zinkernagel, R. M., Production of random classes of immunoglobulins in brain tissue during persistent viral infection paralleled by secretion of interleukin-6(IL-6) but not of IL-4, IL-5, and gamma interferon. J. Virol. 1991. 65: 1364-1369.
30. Moskophidis, D., Löhler, J. and Lehmann-Grube, F., Antiviral antibody-producing cells in parenchymatous organs during persistent virus infection. J. Exp. Med. 1987. 165: 705-709.
31. Scherle, P. and Gerhard, W., Functional analysis of influenza-specific helper T cell clones in vivo. J. Exp. Med. 1986. 164: 1114-1128.
32. Zinkernagel, R. M., Cooper, S., Chambers, J., Lazzarini, R. A., Hengartner, H. and Arnheiter, H., Virus induced autoantibody response to a transgenic viral antigen. Nature 1990. 344: 68-71.
33. Scherle, P. A. and Gerhard, W., Differential ability of B cells specific for external vs. internal influenza virus proteins to respond to help from influenza virus-specific T-cell clones in vivo. Proc. Acad. Sci. USA 1988. 85: 4446-4450.
34. Kündig, T., Castelmur, I., Bachmann, M. F., Abraham, D., Binder, D., Hengartner, H. and Zinkernagel, R. M., Fewer protective cytotoxic T cell epitopes than T helper cell epitopes on vesicular stomatitis virus. J. Virol. 1993. 67: 3680-3683.
35. + T cells correlating with cytotoxic activity in vitro are more efficient in antivaccinia virus protection than CD4-dependent interleukins. J. Immunol. 1991. 146: 4301-4307.
36. Ramshaw, I., Ruby, J., Ramsay, A., Ada, G. and Karupiah, G., Expression of cytokines by recombinant vaccinia viruses: A model for studying cytokines in virus infections in vivo, Immunol. Rev. 1992. 127: 157-182.
37. Whitton, J. L., Gebhard, J. R., Lewicki, H., Tishon, A. and Oldstone, M. B., Molecular definition of a major cytotoxic T-lymphocyte epitope in the glycoprotein of lymphocytic choriomeningitis virus. J. Virol. 1988. 62: 687-695.
38. Schulz, M., Aichele, P., Vollenweider, M., Bobe, F. W., Cardinaux, F., Hengartner, H. and Zinkernagel, R. M., MHC dependent T cell epitopes of LCMV nucleoprotein and their protective capacity against viral disease. Eur. J. Immunol. 1989. 19: 1657-1667.
39. Matsuura, Y., Possee, R. D., Overton, H. A. and Bishop, D. H. L., Baculovirus expression vectors: the requirements for high level expression of proteins, including glycoproteins. J. Gen. Virol. 1987. 68: 1233-1250.
40. + T lymphocyte-mediated antiviral immunity in mice as a result of injection of recombinant viral proteins. J. Immunol. 1994. 153: 2554-2561.
41. Oxenius, A., Bachmann, M. F., Ashton-Rickardt, P. G., Tonegawa, S., Zinkernagel, R. M. and Hengartner, H., Presentation of endogenous viral proteins in association with major histocompatibility complex II: on the role of intracellular compartmentalization, invariant chain and the TAP transporter system. Eur. J. Immunol. 1995. 25: 3402-3411.
42. Pruslin, F. H., Caveats and suggestions for the ELISA. J. Immunol. Methods 1991. 137: 27-35.
43. Chirmnule, N., Misinterpretation of results of cytokine bioassays. J. Immunol. Methods 1991. 137: 141-144.
44. Battegay, M., Moskophidis, D., Waldner, H., Bründler, M. A., Fung, Leung, W. P., Mak, T. W., Hengartner, H. and Zinkernagel, R. M., Impairment and delay of neutralizing antiviral antibody responses by virus specific cytotoxic T cells. J. Immunol. 1993. 151: 5408-5415.
45. Mishell, B. B. and Shiigi, S. M., Modification of bovine gamma globulin with dinitrophenyl hapten. In: Selected methods in cellular immunology. Freeman, San Fancisco 1980, pp 347-350.
46. Cobbold, S. P., Jayasuriya, A., Nash, A., Prospera, T. D. and Waldmann, H., Therapy with monoclonal antibodies by elimination of T cell subsets in vivo. Nature 1984. 312: 548-551.
47. Zinkernagel, R. M., Leist, T. P., Hengartner, H. and Althage, A., Susceptibility to lymphocytic choriomeningitis virus isolates correlates directly with early and high cytotoxic T cell activity, as well as with footpad swelling reaction, and all three are regulated by H-2D. J. Exp. Med. 1985. 162: 2125-2141.